PAVmed (PAVM) Research & Development (2015 - 2026)
PAVmed (PAVM) posted quarterly Research & Development of -$1.7 million for Q4 2025, down 316.48% year-over-year from $807000.0 in Q4 2024, and down 969.15% quarter-over-quarter from $201000.0 in Q3 2025.
PAVmed (PAVM) Research & Development (2015 - 2026) Analysis & Trends
PAVmed's Research & Development history runs 11 years deep, the most recent figure standing at -$1.7 million for Q4 2025.
- In Q4 2025, Research & Development fell 316.48% year-over-year to -$1.7 million; the TTM figure through Dec 2025 stood at $31000.0 (down 99.77% YoY), while the FY2025 annual figure was $917000.0, down 84.54% from the prior year.
- Research & Development for Q4 2025 stood at -$1.7 million, down from $201000.0 in the prior quarter.
- The five-year high for Research & Development was $11.8 million in Q4 2022, with the low at -$4.0 million in Q4 2021.
- The 5-year median for Research & Development is $3.3 million (2021), against an average of $3.0 million.
- The sharpest annual moves came in 2022 and 2025: Research & Development soared 395.73% in 2022, then sank 316.48% in 2025.
- PAVmed's Research & Development stood at -$4.0 million in 2021, then jumped by 395.73% to $11.8 million in 2022, then plunged by 41.4% to $6.9 million in 2023, then plunged by 88.31% to $807000.0 in 2024, then tumbled by 316.48% to -$1.7 million in 2025.
- Business Quant data shows PAVM's Research & Development at -$1.7 million in Q4 2025, $201000.0 in Q3 2025, and $790000.0 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 200.19 Bn | 194.59 Bn | 7.27 Bn | 892.00 Mn |
| 2 | Stryker | 129.95 Bn | 126.47 Bn | 4.50 Bn | 434.00 Mn |
| 3 | Medtronic | 120.06 Bn | 110.84 Bn | 6.41 Bn | 671.00 Mn |
| 4 | Boston Scientific | 74.14 Bn | 73.60 Bn | 3.85 Bn | 554.00 Mn |
| 5 | Edwards Lifesciences | 52.74 Bn | 48.49 Bn | 1.35 Bn | 278.90 Mn |
| 6 | Dexcom | 34.60 Bn | 32.65 Bn | 830.00 Mn | 153.00 Mn |
| 7 | GE HealthCare Technologies | 34.20 Bn | 32.10 Bn | 2.18 Bn | 323.00 Mn |
| 8 | Koninklijke Philips | 26.46 Bn | 23.13 Bn | 4.55 Bn | -562.58 Mn |
| 9 | Steris | 23.25 Bn | 22.77 Bn | 684.20 Mn | 28.60 Mn |
| 10 | PAVmed | 32.79 Mn | 29.00 Mn | -89,000.00 | 2.07 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 2.07 Mn |
| Dec 31, 2025 | -1.75 Mn |
| Sep 30, 2025 | 201,000.00 |
| Jun 30, 2025 | 790,000.00 |
| Mar 31, 2025 | 787,000.00 |
| Dec 31, 2024 | 807,000.00 |
| Jun 30, 2024 | 1.64 Mn |
| Mar 31, 2024 | 4.31 Mn |
| Dec 31, 2023 | 6.90 Mn |
| Sep 30, 2023 | 3.16 Mn |
| Jun 30, 2023 | 3.47 Mn |
| Mar 31, 2023 | 4.54 Mn |
| Dec 31, 2022 | 11.78 Mn |
| Sep 30, 2022 | 6.20 Mn |
| Jun 30, 2022 | 4.90 Mn |
| Mar 31, 2022 | 3.93 Mn |
| Dec 31, 2021 | -3.98 Mn |
| Sep 30, 2021 | 2.29 Mn |
| Jun 30, 2021 | 4.26 Mn |
| Mar 31, 2021 | 3.32 Mn |